Benzinga | Aug 24, 2021 08:33AM EDT

Wedbush Initiates Coverage On Omega Therapeutics with Outperform Rating, Announces Price Target of $36

Wedbush analyst Robert Driscoll initiates coverage on Omega Therapeutics (NASDAQ:OMGA) with a Outperform rating and announces Price Target of $36.